Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension
Durham, North Carolina, 2018-Oct-22 — /EPR Network/ — Vascular BioSciences (VBS) is proud to report the award of Phase II STTR grant funding from the [read full press release…]